pharma · Colorectal Cancer · Esophageal Varices in NASH Cirrhosis · GALT
Galectin Therapeutics
GALECTIN THERAPEUTICS INC
Galectin Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US HQ
2000 Founded
36 Employees
Public company Type
GALT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US
- Founded
- 2000
- Employees
- 36
- Programs
- 12
- Drugs
- 5
- Patents
- 20
Galectin Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Galectin Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Galectin Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Galectin Therapeutics.
-
GR-MD-02 — Phase 1
Clinical update -
Placebo of BELAPECTIN, BELAPECTIN — Phase 3
Clinical update -
GR-MD-02 — Phase 2
Clinical update -
GR-MD-02 — Phase 1
Clinical update -
belapectin — Phase 3
Clinical update -
belapectin — Phase 1
Clinical update -
GM-CT-01 — Phase 2
Clinical update -
GM-CT-01 — Phase 2
Clinical update